Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma

Frontiers in Oncology- Switzerland

doi 10.3389/fonc.2019.01361

Full Text

Abstract

Available in

Date

Authors

Publisher

Frontiers Media SA

Related search

Identification of a RNA-Seq Based Prognostic Signature With Five lncRNAs for Lung Squamous Cell Carcinoma

Oncotarget
Oncology
2017English

Development and Validation of a 28-Gene Hypoxia-Related Prognostic Signature for Localized Prostate Cancer

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2018English

Full-Length Telomerase Reverse Transcriptase Messenger RNA Is an Independent Prognostic Factor in Neuroblastoma

American Journal of Pathology
Forensic MedicinePathology
2003English

Development and Validation of an Immune-Related Gene Pairs Signature in Colorectal Cancer

OncoImmunology
OncologyAllergyImmunology
2019English

SeqAcademy: An Educational Pipeline for RNA-Seq and ChIP-Seq Analysis

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2018English

Development and Internal Validation of a Nine-lncRNA Prognostic Signature for Prediction of Overall Survival in Colorectal Cancer Patients

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2018English

Developing a Prognostic Micro-Rna Signature for Human Cervical Carcinoma

PLoS ONE
Multidisciplinary
2015English

Figure 6: RT-qPCR Validation of RNA-seq Relative Expression Estimation.

English

Retraction Note To: Identification of Core miRNA Based on Small RNA-seq and RNA-seq for Colorectal Cancer by Bioinformatics

Tumor Biology
MedicineCancer Research
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy